What is the ICARA study?

The current medications for Alzheimer’s disease are mostly aimed at maximizing the brain activity. The ICARA study is evaluating the safety and effectiveness of an investigational drug aimed at slowing down the disease progression.

• What is the ICARA study?
• Who can participate?
• How can participants benefit?
• What will participants be asked to do?
• See if you may be eligible
• Where can I enroll?
• For study information outside the
       United States and Canada